Nova Diagnostics And Medicare Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 1.91 M
- Company Age 26 Year, 11 Months
- Last Filing with ROC 31 Mar 2017
- Open Charges ₹ 6.17 M
- Revenue Growth 182.51%
- Profit Growth 2412.20%
- Ebitda 2172.89%
- Net Worth -17.43%
- Total Assets -35.05%
About Nova Diagnostics And Medicare
Nova Diagnostics And Medicare Private Limited (NDAMPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 February 1998 and has a history of 26 years and 11 months. Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.91 M.
The company currently has active open charges totaling ₹6.17 M.
Anshumali Srivastava and Shikha Srivastava serve as directors at the Company.
Company Details
-
Location
Lucknow, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85200UP1998PTC023152
-
Company No.
023152
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Feb 1998
-
Date of AGM
30 Sep 2017
-
Date of Balance Sheet
31 Mar 2017
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Nova Diagnostics And Medicare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anshumali Srivastava
|
Director | 17-Feb-1998 | Current |
|
Shikha Srivastava
|
Director | 13-Dec-2006 | Current |
Financial Performance of Nova Diagnostics And Medicare.
Nova Diagnostics And Medicare Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 182.51% increase. The company also saw a substantial improvement in profitability, with a 2412.2% increase in profit. The company's net worth observed a substantial decline by a decrease of 17.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nova Diagnostics And Medicare?
In 2017, Nova Diagnostics And Medicare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Clairvoyance Biotech (India) LimitedAnshumali Srivastava and Shikha Srivastava are mutual person
Charges (Loans)
₹6.17 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.62 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Nov 2008 | Bank Of India | ₹0.80 M | Open |
| 27 Aug 2004 | Bank Of India | ₹1.00 M | Open |
| 26 Oct 2002 | Bank Of India | ₹3.24 M | Open |
| 06 Aug 2002 | Bank Of India | ₹0.37 M | Open |
| 26 Jun 2001 | Bank Of India | ₹0.64 M | Open |
How Many Employees Work at Nova Diagnostics And Medicare?
Unlock and access historical data on people associated with Nova Diagnostics And Medicare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nova Diagnostics And Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nova Diagnostics And Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
